Literature DB >> 11106237

Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.

Y Yonemura1, Y Endou, K Kimura, S Fushida, E Bandou, K Taniguchi, K Kinoshita, I Ninomiya, K Sugiyama, C W Heizmann, B W Schafer, T Sasaki.   

Abstract

S100A4 is known to be involved in cancer cell motility by virtue of its ability to activate nonmuscle myosin. E-cadherin has an important role in the homophilic cell-cell adhesion and is called an invasion suppressor gene. In the current study, we investigate the histological type and metastatic potential of gastric cancer from the aspect of the interrelationship of E-cadherin and S100A4 expression. Expression of E-cadherin and S100A4 in gastric cancer cell lines, primary gastric cancers, and their normal counterparts were analyzed by reverse transcription-PCR, Western blot, and immunohistochemical methods. S100A4 protein and E-cadherin were expressed in five of eight gastric cancer cell lines, and inverse expression of the two proteins are found in four cell lines. In the clinical specimens, E-cadherin mRNA expression in differentiated adenocarcinomas (88%, 14 of 16) was significantly more frequent than that in poorly differentiated adenocarcinomas (50%, 22 of 44; P = 0.015). Western blot analysis demonstrates that S100A4 protein expression in poorly differentiated adenocarcinomas was 1.6-fold higher than in well differentiated adenocarcinoma. Immunohistochemically, S100A4 expression was detected in 51 (55%) of 92 primary gastric cancers. Reduced expression of E-cadherin in primary tumors was found in 66 (72%) of 92 tumors. S100A4 expression in the poorly differentiated adenocarcinomas had a strong relation to positive lymph node involvement or peritoneal dissemination. Reduced E-cadherin expression showed a strong relationship with positive serosal involvement and infiltrating type. Tumors classified as a group with reduced E-cadherin and high expression of S100A4 reveal positive peritoneal dissemination, serosal involvement, and infiltrating type in the growth pattern. Furthermore, these tumors showed a strong correlation with the poorly differentiated adenocarcinoma. In contrast, tumors with preserved E-cadherin and low expression of S100A4 have a close relation to the well differentiated adenocarcinoma and a favorable prognosis. By the Cox proportional hazard model, S100A4 and E-cadherin tissue status was judged as an independent prognostic factor. S100A4 and E-cadherin tissue status may be a powerful aid in evaluating metastatic potential or the prognosis of patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106237

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  51 in total

1.  Protein S100A4: too long overlooked by pathologists?

Authors:  Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer.

Authors:  Yasuto Uchikado; Hiroshi Okumura; Sumiya Ishigami; Tetsuro Setoyama; Masataka Matsumoto; Tetsuhiro Owaki; Yoshiaki Kita; Shoji Natsugoe
Journal:  Gastric Cancer       Date:  2011-01-28       Impact factor: 7.370

3.  S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.

Authors:  Dong Chen; Xue-Feng Zheng; Ze-You Yang; Dong-Xiao Liu; Guo-You Zhang; Xue-Long Jiao; Hui Zhao
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

4.  S100A4 downregulates filopodia formation through increased dynamic instability.

Authors:  Connie Goh Then Sin; Nils Hersch; Philip S Rudland; Roger Barraclough; Bernd Hoffmann; Stephane R Gross
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

Review 5.  Modern imaging techniques for preoperative detection of distant metastases in gastric cancer.

Authors:  Robert M Kwee; Thomas C Kwee
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

6.  PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.

Authors:  Jaroslaw Jendrzejewski; Andrew Thomas; Sandya Liyanarachchi; Andrew Eiterman; Jerneja Tomsic; Huiling He; Hanna S Radomska; Wei Li; Rebecca Nagy; Krzysztof Sworczak; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2015-08-14       Impact factor: 5.958

7.  Self-association of calcium-binding protein S100A4 and metastasis.

Authors:  Thamir M Ismail; Shu Zhang; David G Fernig; Stephane Gross; Marisa L Martin-Fernandez; Violaine See; Kaeko Tozawa; Christopher J Tynan; Guozheng Wang; Mark C Wilkinson; Philip S Rudland; Roger Barraclough
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

8.  Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

Authors:  Ke Yin; Qiande Liao; Hongbo He; Da Zhong
Journal:  Med Oncol       Date:  2012-07-31       Impact factor: 3.064

9.  Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.

Authors:  Nuria Mencía; Elisabet Selga; Isabel Rico; M Cristina de Almagro; Xenia Villalobos; Sara Ramirez; Jaume Adan; Jose L Hernández; Véronique Noé; Carlos J Ciudad
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

10.  Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.

Authors:  M Anders; M Vieth; C Röcken; M Ebert; M Pross; S Gretschel; P M Schlag; B Wiedenmann; W Kemmner; M Höcker
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.